Compare RJET & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RJET | BLFS |
|---|---|---|
| Founded | 1982 | 1987 |
| Country | United States | United States |
| Employees | 8400 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 930.0M | 923.5M |
| IPO Year | N/A | 2013 |
| Metric | RJET | BLFS |
|---|---|---|
| Price | $20.63 | $24.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 106.8K | ★ 366.8K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | ★ $0.21 | $1,146.75 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $15.37 | $17.86 |
| 52 Week High | $23.88 | $29.57 |
| Indicator | RJET | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 52.28 | 66.34 |
| Support Level | $16.65 | $23.74 |
| Resistance Level | $21.31 | $26.30 |
| Average True Range (ATR) | 1.79 | 1.09 |
| MACD | -0.13 | 0.17 |
| Stochastic Oscillator | 54.30 | 92.62 |
Republic Airways Holdings Inc is a regional airline mainly in North America. The company provides scheduled passenger service through its mainline partnerships with American Airlines, Delta Air Lines, and United Airlines. Republic offers scheduled passenger service on several daily flights to various cities in the United States, Canada, Mexico, and the Caribbean. It exclusively operates the dual-class Embraer E170/175 family of aircraft, and provides its services under the American Eagle, Delta Connection, or United Express brands. The company is organized and operates as one operating and reportable segment: regional airline services.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.